title: Psychotic disorder as a manifestation of Graves' disease.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Katsigiannopoulos
authors.forename: Elena
authors.initials: E
authors.lastname: Georgiadou
authors.forename: Pandelis
authors.initials: P
authors.lastname: Pazarlis
authors.forename: Anastasia
authors.initials: A
authors.lastname: Karastergiou
authors.forename: Georgios
authors.initials: G
authors.lastname: Papazisis
authors.forename: Vasilios
authors.initials: V
authors.lastname: Bozikas
authors.forename: George
authors.initials: G
authors.lastname: Garyfallos
mesh_terms: D000368:Aged; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology*; D013469:Sulpiride / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D013956:Antithyroid Agents; D008713:Methimazole; D013469:Sulpiride; D000077582:Amisulpride